Cantor Fitzgerald reissued an “overweight” rating and issued a $315.00 price objective on shares of HCA Healthcare in a research report on Thursday, September 14th.

Source: https://www.etfdailynews.com/2023/11/30/cibc-world-market-inc-buys-19927-shares-of-hca-healthcare-inc-nysehca/

Covestor Ltd lifted its position in shares of HCA Healthcare by 122.7% in the first quarter.

Source: https://www.americanbankingnews.com/2023/12/10/mml-investors-services-llc-has-5-42-million-stock-holdings-in-hca-healthcare-inc-nysehca.html

Covestor Ltd raised its stake in shares of HCA Healthcare by 122.7% during the 1st quarter.

Source: https://www.etfdailynews.com/2023/03/03/healthcare-of-ontario-pension-plan-trust-fund-takes-194000-position-in-hca-healthcare-inc-nysehca/

Finally, Credit Suisse Group lowered their price target on HCA Healthcare to $240.00 in a report on Thursday, October 27th.

Source: https://www.etfdailynews.com/2023/01/06/ae-wealth-management-llc-acquires-2211-shares-of-hca-healthcare-inc-nysehca/

HCA Healthcare had a negative return on equity of 118,732.40% and a net margin of 8.99%.

Source: https://www.etfdailynews.com/2023/01/06/ae-wealth-management-llc-acquires-2211-shares-of-hca-healthcare-inc-nysehca/

HCA Healthcare is committed to providing equitable access to high-quality care for patients and fostering a diverse and inclusive workplace for its colleagues.

Source: https://www.marketscreener.com/quote/stock/HCA-HEALTHCARE-INC-7534808/news/HCA-Healthcare-Named-as-One-of-the-2023-World-s-Most-Ethical-Companies-43230615/?utm_medium=RSS&utm_content=20230313

James Investment Research Inc. purchased a new stake in HCA Healthcare during the 1st quarter valued at approximately $31,000.

Source: https://www.americanbankingnews.com/2023/10/27/hca-healthcare-nysehca-given-new-275-00-price-target-at-mizuho.html

James Investment Research Inc. purchased a new stake in HCA Healthcare in the 1st quarter valued at about $31,000.

Source: https://www.etfdailynews.com/2023/09/24/hca-healthcare-inc-nysehca-shares-sold-by-lbmc-investment-advisors-llc/

Mizuho increased their target price on shares of HCA Healthcare from $265.00 to $279.00 and gave the company a “buy” rating in a report on Monday.

Source: https://www.americanbankingnews.com/2023/01/31/commerce-bank-purchases-138-shares-of-hca-healthcare-inc-nysehca.html

RB Capital Management LLC increased its stake in HCA Healthcare by 25.9% during the 1st quarter.

Source: https://www.americanbankingnews.com/2023/09/24/congress-wealth-management-llc-de-cuts-stake-in-hca-healthcare-inc-nysehca.html

Sanford C. Bernstein upped their target price on shares of HCA Healthcare from $310.00 to $345.00 in a research report on Tuesday, April 25th.

Source: https://www.dailypolitical.com/2023/08/16/hca-healthcare-inc-nysehca-sees-significant-drop-in-short-interest.html

Stephens reiterated an “overweight” rating and issued a $283.00 target price on shares of HCA Healthcare in a research note on Friday, April 21st.

Source: https://www.etfdailynews.com/2023/06/26/hb-wealth-management-llc-boosts-stock-holdings-in-hca-healthcare-inc-nysehca/

UBS Group lifted their price target on HCA Healthcare from $237.00 to $296.00 and gave the company a buy rating in a research note on Friday, January 13th.

Source: https://www.etfdailynews.com/2023/04/25/hca-healthcare-nysehca-price-target-increased-to-310-00-by-analysts-at-oppenheimer/

Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (

Source: https://www.etfdailynews.com/2023/01/06/ae-wealth-management-llc-acquires-2211-shares-of-hca-healthcare-inc-nysehca/